Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: Lack of influence of chronic perphenazine treatment

B. Spivak; N. Kosower; Y. Zipser; N. Shreiber-Schul; A. Apter; S. Tyano; A. Weizman

doi:10.1097/00002826-199402000-00009

Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: Lack of influence of chronic perphenazine treatment

B. Spivak, N. Kosower, Y. Zipser, N. Shreiber-Schul, A. Apter, S. Tyano, A. Weizman

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

We investigated the possible relationship between schizophrenia, neuroleptic treatment, and platelet monoamine oxidase (MAO) activity. Platelet MAO activity was similar in neuroleptic-naive schizophrenic patients and healthy controls and was not affected by chronic (10-week) perphenazine treatment. A relationship between platelet MAO activity and central disturbances in schizophrenia remains uncertain.

Original language	English
Pages (from-to)	83-88
Number of pages	6
Journal	Clinical Neuropharmacology
Volume	17
Issue number	1
DOIs	https://doi.org/10.1097/00002826-199402000-00009
State	Published - 1994
Externally published	Yes

Keywords

Monoamine oxidase
Perphenazine
Platelets
Schizophrenia

Access to Document

10.1097/00002826-199402000-00009

Cite this

@article{c04aebc28a9247c7aca376364db4947a,

title = "Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: Lack of influence of chronic perphenazine treatment",

abstract = "We investigated the possible relationship between schizophrenia, neuroleptic treatment, and platelet monoamine oxidase (MAO) activity. Platelet MAO activity was similar in neuroleptic-naive schizophrenic patients and healthy controls and was not affected by chronic (10-week) perphenazine treatment. A relationship between platelet MAO activity and central disturbances in schizophrenia remains uncertain.",

keywords = "Monoamine oxidase, Perphenazine, Platelets, Schizophrenia",

author = "B. Spivak and N. Kosower and Y. Zipser and N. Shreiber-Schul and A. Apter and S. Tyano and A. Weizman",

year = "1994",

doi = "10.1097/00002826-199402000-00009",

language = "אנגלית",

volume = "17",

pages = "83--88",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "1",

}

TY - JOUR

T1 - Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients

T2 - Lack of influence of chronic perphenazine treatment

AU - Spivak, B.

AU - Kosower, N.

AU - Zipser, Y.

AU - Shreiber-Schul, N.

AU - Apter, A.

AU - Tyano, S.

AU - Weizman, A.

PY - 1994

Y1 - 1994

N2 - We investigated the possible relationship between schizophrenia, neuroleptic treatment, and platelet monoamine oxidase (MAO) activity. Platelet MAO activity was similar in neuroleptic-naive schizophrenic patients and healthy controls and was not affected by chronic (10-week) perphenazine treatment. A relationship between platelet MAO activity and central disturbances in schizophrenia remains uncertain.

AB - We investigated the possible relationship between schizophrenia, neuroleptic treatment, and platelet monoamine oxidase (MAO) activity. Platelet MAO activity was similar in neuroleptic-naive schizophrenic patients and healthy controls and was not affected by chronic (10-week) perphenazine treatment. A relationship between platelet MAO activity and central disturbances in schizophrenia remains uncertain.

KW - Monoamine oxidase

KW - Perphenazine

KW - Platelets

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0027976847&partnerID=8YFLogxK

U2 - 10.1097/00002826-199402000-00009

DO - 10.1097/00002826-199402000-00009

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 8149362

AN - SCOPUS:0027976847

SN - 0362-5664

VL - 17

SP - 83

EP - 88

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 1

ER -

Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: Lack of influence of chronic perphenazine treatment

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this